Haagsma, C J <br/><br/>
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.  [electronic resource] 

 -  Annals of the rheumatic diseases  Feb 1999 
 - 79-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.58.2.79  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--blood<br/>Digestive System--drug effects<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Folic Acid--blood<br/>Homocysteine--blood<br/>Humans<br/>Male<br/>Methotrexate--adverse effects<br/>Methylenetetrahydrofolate Reductase (NADPH2)<br/>Middle Aged<br/>Mutation<br/>Oxidoreductases Acting on CH-NH Group Donors--genetics<br/>Sulfasalazine--adverse effects<br/>Vitamin B 12--blood